Next Generation News and Research

RSS

ViPS introduces comprehensive software solutions for health payer customers

ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers -- organizations liable for healthcare coverage for plan members or beneficiaries -- stop healthcare fraud, waste and abuse (FWA).

18 Nov 2009

Medtronic introduces new TSRH 3Dx Spinal System to address multiple pathologies

Medtronic, Inc., today announced the launch of the TSRH® 3Dx™ Spinal System. Designed with procedural efficiency in mind, the TSRH 3Dx Spinal System offers two screws designed to address multiple pathologies.

17 Nov 2009

World Heart, LaunchPoint Technologies sign license agreements

World Heart Corporation (WorldHeart) announced today that it has finalized assignment and exclusive license agreements with LaunchPoint Technologies Inc., (LPT) Goleta, California, and Carnegie Mellon University (CMU), Pittsburgh, Pennsylvania for its next-generation minimally invasive blood pump, the MiVAD. The MiVAD(TM) is designed to provide partial cardiac support between 2-4 liters per minute to less sick heart failure patients than those served by existing full-support Left Ventricular Assist Devices (LVADs).

17 Nov 2009

Helicos Genetic Analysis System to be installed at the Leiden Genome Technology Center

Helicos BioSciences Corporation, today announced the sale of a Helicos® Genetic Analysis System to a collaborative Dutch research group led by the Leiden University Medical Center (LUMC), further including the medical centers of Amsterdam (AMC) Groningen (UMCG) and Rotterdam (Erasmus MC) and funded by a grant from NWO, the Netherlands Organization of Scientific Research.

17 Nov 2009

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Arizona State University has been awarded nearly $3 million in federal stimulus funds from the National Institutes of Health. ASU professors Stuart Lindsay and Paul Westerhoff will lead a pair of two-year, innovative projects designed to tackle challenges in the fields of rapid DNA sequencing and the potential health risks of nanotechnology.

17 Nov 2009

Onyx Pharmaceuticals acquires Proteolix

Onyx Pharmaceuticals, Inc. today announced that the company has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.

16 Nov 2009

RXi Pharmaceuticals announces financial results for the quarter ended September 30, 2009

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.

16 Nov 2009

Low-cost, simple interventions could save 2.5 million child lives a year: World Vision

Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes.

16 Nov 2009

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.

16 Nov 2009

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

M3 USA, together with Bristol-Myers Squibb, is launching a pilot program to oncologists using M3’s next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology.

13 Nov 2009

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

CNS PHARMACEUTICALS AG, (C35.F) a developer and marketer of patented natural nutraceutical products is pleased to announce that the Company’s common shares is sponsored by the German Securities Trading Bank 886 AG Wertpapier Handelsbank on the electronic trading platform Xetra.

13 Nov 2009

New science of happiness doing a profound disservice

The new sciences of happiness are generating lots of advice on how to keep smiling. The results are even being explored by policy wonks. So why does so much of it - work less, say thanks, keep fit - sound so trite? If it were that easy, wouldn't we all be happy by now? The reason is that a central and tricky question is being glossed over: just what is happiness? Moreover, how you try to promote happiness depends entirely on what you take happiness to be - and there's a wealth of choice in that.

13 Nov 2009

SpinalMotion submits Kineflex lumbar artificial disc PMA to FDA

SpinalMotion, developer of the investigational Kineflex® lumbar and Kineflex/C® cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has submitted the Pre-Market Approval (PMA) to FDA for the Kineflex lumbar artificial disc

13 Nov 2009

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

Mithridion, Inc., a biopharmaceutical company focusing on developing drugs for serious Central Nervous System (CNS) disorders, announced today progress with its pipeline of potential oral small-molecule drugs for Alzheimer's disease (AD) and schizophrenia.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

K2M announces the launch of TERRA NOVA and SERENGETI

K2M, Inc., the spinal device company developing innovative and simplified solutions for the treatment of complex spinal pathologies and procedures, today announced the launch of the TERRA NOVA® Minimally Invasive Access System and the SERENGETI® Disposable Kit at the North American Spine Society (NASS) 2009 Annual Conference.

12 Nov 2009

Nicast to launch the NovaMesh intra-abdominal hernia mesh in Europe

Nicast, developer of medical devices made of electrospun nanofabric, announced today it is readying to launch the NovaMesh intra-abdominal hernia mesh in the European market in Q1 2010, pending European regulatory approval. NovaMesh is the first intra-abdominal hernia mesh to utilize the special properties of electrospun nanofabric.

12 Nov 2009

IMS Health to launch comprehensive analytical tool for oncology market

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company’s clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.

12 Nov 2009

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Ocutec Ltd, the medical devices specialist today announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene )glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses.

11 Nov 2009

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States

11 Nov 2009

Next Generation News and Research

ViPS introduces comprehensive software solutions for health payer customers

Medtronic introduces new TSRH 3Dx Spinal System to address multiple pathologies

World Heart, LaunchPoint Technologies sign license agreements

Helicos Genetic Analysis System to be installed at the Leiden Genome Technology Center

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Onyx Pharmaceuticals acquires Proteolix

RXi Pharmaceuticals announces financial results for the quarter ended September 30, 2009

Low-cost, simple interventions could save 2.5 million child lives a year: World Vision

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

New science of happiness doing a profound disservice

SpinalMotion submits Kineflex lumbar artificial disc PMA to FDA

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

K2M announces the launch of TERRA NOVA and SERENGETI

Nicast to launch the NovaMesh intra-abdominal hernia mesh in Europe

IMS Health to launch comprehensive analytical tool for oncology market

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News